Learn more about Diversity in Clinical Research and COA Development

Access webinar

Molecules

Reflections on development and localization of COA content for diverse clinical trial participants

Watch the webinar with Lionbridge to explore the role of diversity in endpoint development and generalizable outcomes. Attendees will delve into why including diverse samples in Clinical Outcome Assessments (COAs) development is critical.

You'll discover the importance of bias reduction in COA Development and review COA translation and adaptation methodology. Join our experts:

  • Lynsey Psimas, Ph.D., Pearson Clinical Assessment’s Director of Business Development
  • Melinda Johnson, Director of Lionbridge Global COA Operations
  • Pia Windelov, VP of Lionbridge Life Sciences Strategy and Product Marketing

This session is perfect for clinical research and industry professionals, including:

  • Licensees (Sponsors, CROs)
  • Key Opinion Leaders
  • Academics involved in clinical trial research

Did you enjoy this webinar?

Access more Pearson Pharma Services webinars like Testing cognition in clinical drug trials for Alzheimer's disease featuring Dr. John Harrison. 

Learn more

Meet the Moderator and Featured Experts

Lynsey Psimas

Lynsey Psimas

Ph.D., Director of Business Development, Pearson Clinical Assessments

Dr. Lynsey Psimas is a Licensed Clinical Psychologist with over a decade of industry experience specializing in clinical outcomes assessments and neuropsychological evaluations. In her current role at Pearson Clinical Assessments, she leverages her deep expertise in licensing, COAs, and neurodevelopmental disorders. Dr. Psimas has also worked in academia and private practice, reflecting her diverse skill set and commitment to advancing psychological science.

Melinda Johnson

Melinda Johnson

Director, Global COA Operations, Lionbridge

As Director of Global Clinical Outcome Assessment (COA) Operations, Melinda draws on her linguistic background and deep COA domain expertise. She helps improve patient-centered research and tailors solutions for customers’ needs, including quality, timeliness, and innovation.

Pia Windelov

Pia Windelov

VP, Life Sciences Strategy and Product Marketing, Lionbridge

Pia has worked for two decades in R&D and across multiple therapeutic areas in pharmaceutical and MedTech industries.  She has managed projects within medical device development, Companion Diagnostics, and clinical drug development. Pia was also a key contributor to the Good Lay Summary Practice guidance published on EudraLex, Volume 10, as part of the Clinical Trials guidelines under the EU Clinical Trials Regulation. Educated in linguistics, intercultural communication, and project management, Pia bridges Life Sciences and linguistics to assist customers.

Complete the form to access the on-demand webinar